Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating lemborexant and its metabolites in subjects with normal renal function or severe renal impairment has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Eisai Inc. | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2020-01-18